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a–g Saudi ArabiaObjective: To characterize risk profile of acute coronary syndrome (ACS) patients in different age groups and
compare management provided to in-hospital outcome.
Design: Prospective multi-hospital registry.
Setting: Seventeen secondary and tertiary care hospitals in Saudi Arabia.
Patients: Five thousand and fifty-five patients with ACS. They were divided into four groups: 640 years, 41–
55 years, 56–70 years and P70 years. Main outcome measures: prevalence, utilization and mortality.
Results: Ninety-four percent of patients <40 years compared to 68% of patients >70 years were men. Diabetes was
present in 70% of patients aged 56–70 years. Smoking was present in 66% of those <40 years compared to 7% of
patients >70 years. Fifty-three percent of the patients >70 years and 25% of those <40 years had history of ischemic
heart disease. Sixty percent of patients <40 years presented with ST elevation myocardial infarction (STEMI) while
non-ST elevation myocardial infarction was the presentation in 49% of patients >70 years. Thirty-four percent of
patients >70 years compared to 10% of patients <40 years presented >12 h from symptom onset with STEMI.
Fifty-four percent of patients >70 compared to 64–71% of those <70 years had coronary angiography. Twenty-four
percent of patients >70 compared to 34–40% of those <70 years had percutaneous coronary intervention. Reperfusion
shortfall for STEMI was 16–18% in patients >56 years compared to 11% in patients <40 years. Mortality was 7% in
patients >70 years compared to 1.6–3% in patients <70 years. For all comparisons (p < 0.001).
Conclusions: Young and old ACS patients have unique risk factors and present differently. Older patients have
higher in-hospital mortality as they are treated less aggressively. There is an urgent need for a national prevention1016–7315  2011 King Saud University.
Production and hosting by Elsevier B.V. All rights reserved.
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2012;24:9–16program as well as a systematic improvement in the care for patients with ACS including a system of care for STEMI
patients. For older patients there is a need to identify medical as well as social factors that influence the therapeutic
management plans.
 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
Keywords: Age, Mortality, In-hospital outcome, Acute coronary syndromeAge is a recognized determinant of outcome inacute coronary syndromes (ACS) [1]. In the
Global Registry of Acute Coronary Events
(GRACE) registry age was found to be an indepen-
dent prognostic predictor of hospital mortality
across the entire spectrum of ACS in general clini-
cal practice with an odds ratio of 1.70 per 10 year
increment [2]. Although age above 65 years is part
of the TIMI risk score, the utilization of angiogra-
phy and revascularization has been found to be less
in the elderly [3]. No comparable data exist for Sau-
di Arabia. The Saudi Project for the Assessment of
Coronary Events (SPACE) registry was designed to
study ACS. By studying the characteristics of pa-
tients it would be possible to target interventions
suitable for each age group in order to reduce the
burden of modifiable risk factors, optimize out-
come and follow evidence based practice.Methods
Patient population and methods
SPACE was a prospective registry of all consec-
utive ACS patients that were admitted to 17 par-
ticipating hospitals. The diagnosis of different
types of ACS as well as the definitions of the terms
used was based on the definitions of American
College of Cardiology (ACC) [4]. Current smoking
was defined as having smoked cigarettes or tobac-
co within the previous 12 months. The study de-
sign, population, data collection and organization
have been previously described [5].
For the purpose of this analysis patients were di-
vided into four groups: 640 years, 41–55 years, 56–
70 years and P70 years.Study organization
Data collected included demographics, medical
history including the presence of known cardio-
vascular risk factors, diagnosis on admission and
final discharge diagnosis, ECG findings, labora-
tory investigations, medical therapy, use of car-
diac procedures and interventions, in-hospital
outcomes, and mortality. Ethical approval was ob-
tained in all participating centers.Statistical analysis
Categorical data were summarized with absolute
numbers and percentages. Continuous data were
summarized with means and standard deviations
(SD) or median and inter-quartile range (IQR).
Comparisons among different groups were per-
formed using Chi-square test for categorical vari-
ables and analysis of variance or Kruskal–Wallis
test for continuous variables. Whenever needed
Bonferroni correction was used to adjust for multi-
ple comparisons. Cochran–Armitage trend test
was used to test the statistical significance of the
observed trend in in-hospital outcome across dif-
ferent age groups. Multiple logistic regression
analysis was used to estimate the adjusted odds ra-
tios. Adjustments were made for, gender, body
mass index (BMI), smoking, hyperlipidaemia, dia-
betes, hypertension, heart rate, systolic blood pres-
sure, past history of IHD, peripheral artery disease
(PAD), diagnostic coronary angiography, PCI,
CABG, and all pharmacological therapies. All
analyses were performed using [SAS/STAT] soft-
ware, Version [9.1.3] (SAS Institute Inc., Cary,
NC, USA).Results
Baseline patient characteristics
The SPACE registry collected data on 5055
patients from 17 participating hospitals between
December 2005 and December 2007 (Table 1).
Patient’s age ranged from 18 to 111 years with a
mean of 58 years. Seventy-five percent were 41–
70 years, 9% 640 years while 16% were >70 years.
Women were increasingly represented with
increasing age, comprising 6% of patients
640 years and reaching 32% of patients >70 years
(p < 0.001). Saudi citizens predominated in all
age groups, and the proportion increased with
increasing age (p < 0.001). PatientsP56 years were
more likely to have diabetes mellitus and hyper-
tension. Hyperlipidemia varied among age groups
from approximately one-third to almost one-half,
peaking in those aged 56–70 years (p < 0.001).
The prevalence of smoking was highest in patients
aged 640 years and was least in those >70 years
Table 1. Patients’ baseline characteristics.
Variables Overall Age
<40 years
Age 41–
55 years
Age 56–
70 years
Age > 70 years p
value
n (%) 5055(100) 440(9) 1835(36) 1951(39) 829(16)
Mean age (SD) (years) 58.01(12.92) 36.1(4.13) 48.8(4.06) 63.2(4.22) 77.8(5.92)
Male sex, n (%) 3919(77) 412(94) 1538(84) 1404(72) 565(68) <0.001
Saudi nationality, n (%) 4167(82) 289(66) 1332(73) 1752(90) 794(96) <0.001
Diabetes mellitus, n (%) 2933(58) 113(26) 941(51) 1373(70) 506(61) <0.001
Hypertension, n (%) 2785(55) 121(28) 839(46) 1283(66) 542(66) <0.001
Current smoker, n (%) 1636(32) 291(66) 875(48) 413(21) 57(7) <0.001
Hyperlipidemia, n (%) 2086(41) 138(32) 704(39) 933(48) 311(38) <0.001
History of IHD, n (%) 1568(45) 111(25) 682(37) 915(47) 438(53) <0.001
History of PCI, n (%) 700(13) 40(9) 247(13) 304(16) 109(13) <0.001
History of CABG, n (%) 296(6) 7(2) 70(4) 131(7) 88(11) <0.001
History of CVA/TIA, n (%) 309(6) 5(1) 54(3) 152(8) 98(12) <0.001
History of PAD, n (%) 364(7) 10(2) 94(5) 152(8) 108(13) <0.001
Ambulance use, n (%) 186(5) 14(4) 78(6) 62(5) 32(5) 0.168
Ischemic chest pain, n (%) 3057(88) 284(93) 1173(91) 1142(86) 458(80) <0.023
SBP 6 90 mmHg, n (%) 148(3) 13(3) 53(3) 57(3) 25(3) 0.999
HRP 100 beats per minute, n (%) 679(15) 53(13) 238(14) 262(15) 126(16) 0.491
Presenting with KILLIP class > 1, n (%) 937(21) 54(13) 249(15) 394(23) 240(31) <0.001
STEMI, n (%) 2096(41) 263(60) 883(48) 691(35) 259(31) <0.001
STEMI presenting first to a registry hospital within
12 h from symptom onset, n (%)
912(74) 159(87) 413(79) 248(67) 92(59) <0.001
STEMI presenting first to a registry hospital beyond
12 h from symptom onset, n (%)
260(21) 18(10) 89(17) 100(27) 53(34) <0.001
NSTEMI, n (%) 1841(36) 112(25) 526(29) 801(41) 402(49) <0.001
Unstable angina, n (%) 1118(22) 65(15) 426(23) 459(24) 168(20) <0.001
NSTEMI = non-ST elevation acute myocardial infarction; STEMI = ST elevation myocardial infarction; IHD = ischemic heart disease; PCI = percu-
taneous coronary intervention; CABG = coronary artery bypass graft; CVA/TIA = cerebrovascular accident/transient ischemic attack; SBP = systolic
blood pressure; HR = heart rate. PAD = peripheral arterial disease.
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heart disease (IHD) increased with age and was
highest in those >70 years (p < 0.001).ACS type, clinical presentation and extent of
disease by age
Of the 5055 patients, 2096 (41%) presented
with STEMI, 1841 (36%) with NSTEMI, and
1118 (22%) with UA. NSTEMI increased with
age from 25% of patients aged 640 years to
49% of patients aged >70 years (p < 0.001). Con-
versely, STEMI decreased with increasing age
from 60% of patients aged 6 40 years to 31%
of patients aged >70 years (p < 0.001). As age in-
creased, patients with STEMI were less likely to
present to a registry hospital within 12 h from
symptom onset (p < 0.001). UA was of lesser fre-
quency (15%) in patients aged 640 years than in
the other age groups (20–24%; p < 0.001). Of the
two-thirds of patients with an angiogram, single
vessel disease was less prevalent with increasing
age, while three-vessel or left main disease was
more common in older patients (p < 0.001). A
presentation in Killip class >1 increased with
age (p < 0.001). Admission creatinine was higher
with increasing age (p < 0.001).In-hospital treatment
The use of aspirin, clopidogrel and statins was
similar among age groups (Table 2). There was a
trend for less use of beta blockers (BB) with
increasing age (p = 0.003). Patients aged 640 years
were less likely to be treated with either an angio-
tensin converting enzyme inhibitor (ACEI) and or
angiotensin receptor blocker (ARB) (p < 0.001).
Among STEMI patients arriving to a registry
hospital within 12 h from symptom onset those
aged 56 or more were less likely to receive throm-
bolytic therapy but were more likely to be treated
with primary PCI (p < 0.001). Patients older than
56 years had the highest reperfusion shortfall with
between 16% and 18% not receiving any reperfu-
sion therapy (p < 0.001). The median door-
to-needle time for STEMI patients receiving
thrombolytic therapy was 53 min for the entire
cohort, and increased with increasing age, from a
median of 50 min in patients aged 656 years to
84 min in those aged >70 years (p = 0.009). Patients
>70 years were less likely to get an angiogram, re-
ceive a glycoprotein IIb/IIIa inhibitor or be treated
by PCI (p < 0.001). Patients in the age group 56–
70 years were more likely than other age groups
to be treated by coronary artery bypass graft sur-
gery (CABG).
Table 2. In-hospital treatment.
Therapies used Overall Age
<40 years
Age 41–
55 years
Age 56–
70 years
Age
>70 years
p
Value
n (%) 5055(100) 440(9) 1835(36) 1951(39) 829(16)
Aspirin, n (%) 4935(97) 432(98) 1795(98) 1903(97) 805(97) 0.321
Clopidogrel, n (%) 4232(84) 357(81) 1543(84) 1630(83) 702(85) 0.542
Beta-blockers, n (%) 4121(81) 375(85) 1518(83) 1583(81) 645(78) 0.003
ACEI/ARB, n (%) 3805(75) 292(66) 1345(73) 1524(78) 644(78) <0.001
STATIN, n (%) 4711(93) 408(93) 1725(94) 1814(93) 764(92) 0.429
Thrombolytic therapy for STEMI within 12 h from symptom
onset, n (%)
627(69) 116(73) 305(74) 151(61) 55(60) <0.001
Primary PCI within 12 h from symptom onset, n (%) 158(17) 25(16) 58(14) 53(21) 22(24) <0.001
Reperfusion shortfall in STEMI patients initially presenting
within 12 h to a registry hospital, n (%)
127(14) 18(11) 50(12) 44(18) 15(16) <0.001
Coronary angiogram, n (%) 3403(67) 282(64) 1280(70) 1390(71) 451(54) <0.001
Non critical disease, n (%) 58(2) 19(7) 27(2) 9(1) 3(1) <0.001
Single vessel CAD, n (%) 1074(32) 131(47) 464(37) 393(29) 86(20) <0.001
Two vessel CAD, n (%) 745(22) 50(18) 280(22) 316(23) 99(22) 0.345
Triple Vessel CAD, n (%) 1144(34) 44(16) 361(28) 531(38) 208(46) <0.001
Left Main CAD, n (%) 162(5) 5(2) 42(3) 71(5) 44(10) <0.001
GP IIb/IIIa inhibitor, n (%) 1387(27) 121(28) 542(30) 541(28) 183(22) <0.001
PCI, n (%) 1778(35) 172(39) 735(40) 671(34) 200(24) <0.001
CABG, n (%) 425(8) 17(4) 146(8) 201(10) 61(7) <0.001
PCI = percutaneous coronary intervention; CABG = coronary artery bypass graft surgery. STEMI = ST elevation acute myocardial infarction. ACE-I/
ARB = angiotensin converting enzyme inhibitor and/or angiotensin receptor blocker; GP IIb/IIIa inhibitor = glycoprotein IIb/IIIa inhibitors.
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Recurrent myocardial infarction occurred in 77
patients (1.5%), and did not vary among age groups
(p = 0.108) (Table 3). Older patients were more
likely to develop heart failure, cardiogenic shock
or have a major non-surgical bleed (p < 0.001).
Overall, 155 patients (3%) died. In-hospital mortal-
ity increased from <2% of patients aged <56 years
to 7% of patients aged >70 years (p < 0.001). Follow-
ing adjustment for several variables the adjusted
odds ratio for mortality was 0.25 for patients 41–
55 years and 0.33 for patients 56–70 years in com-
parison to those >70 years and 0.45 for heart failure
development in patients aged 41–55 years in
comparison to those >70 years (both p < 0.001)
(Table 4).Discussion
The SPACE registry which is the first of its kind
in Saudi Arabia documented characteristics of
patients, measured quality indicators including
in-hospital outcome and allowed comparison with
other published registries and studies worldwide.
Age and risk factors
SPACE registry patients, with a mean age of
58 years, were eight years younger than the mean
age of 66 years in (GRACE) registry, and six years
younger than the median of 64 years for ACC
National Cardiovascular Data Registry (NCDR)
Acute Coronary Treatment and Intervention Out-comes Network (ACTION) registry [6,7]. ACS
patients of similar age to SPACE registry patients
include Gulf RACE ACS registry patients from six
Gulf countries with a mean age of 55 years [8] and
the CREATE registry from India with a mean age
of 57 years [9]. In a 2000–2001 Euro Heart survey
only 23% of the patients were aged <55 years
while 25% were >75 years of age [10]. It is likely
that younger age in this registry reflects higher
prevalence of risk factors in the population in
addition to the fact that there is currently consid-
erably fewer persons aged >65 years in Saudi
Arabia compared with most Western countries.
In 2011, 3% of Saudis were agedP65 years, which
is much less than the 13.1% in the US or 16% or
more in most of the European countries [11].
One alarming finding from this registry is that
66% of those below the age of 40 years were cur-
rent smokers while the overall rate of current
smokers was 32%. This is less than the 36.6% seen
in the Gulf RACE registry. The prevalence of cur-
rent smokers in a 1995–2000 nationwide Saudi epi-
demiological health survey of 17,350 Saudi adults
was 18.1% for men aged 30–39 years and 4.5% for
women in the same age group [12]. Results of
other surveys suggest that the pool of smokers is
being fed by Saudis who begin smoking at youn-
ger ages. A recent survey of Riyadh Health Sci-
ences College students revealed current smoking
(within the past month) to be 32.7% among male
and 6% among female students aged 19–25 years
[13]. These results emphasize the urgent need
for national policies for primary and secondary
Table 3. In-hospital outcome.
Variables Overall,
n (%)
Age
below
40 years
Age 41–
55 years
Age 56–
70 years
Age
more
than
70 years
p Value
using
Chi-square
test
p Value using
Cochran–Armitage
trend test
Death, n (%) 155(3.0) 8(1.8) 30(1.6) 58(3) 59(7) <0.001 <0.001
Recurrent myocardial
infarction, n (%)
77(1.5) 4(1) 24(1.3) 29(1.5) 20(2.4) 0.108 0.0127
Non-surgical major
bleeding, n (%)
68(1.3) 4(1) 6(0.3) 42(2) 16(1.9) <0.001 <0.001
Stroke, n (%) 48(0.9) 3(0.6) 13(0.7) 20(1) 12(1.5) 0.29 0.033
Heart failure during
hospitalization, n (%)
520(10.2) 19(4.3) 115(6.2) 258(13) 128(15) <0.001 <0.001
Cardiogenic shock, n (%) 222(4.4) 17(3.8) 58(3) 92(4.7) 55(6.6) <0.001 <0.001
Table 4. Multivariate analysis for in-hospital outcome.
Outcomes Age in years OR(95% CI) p Value Adjusted OR p Value
Death 640 0.24(0.11–0.51) <0.001 0.30(0.06–1.44) 0.1345
41–55 0.21(0.13–0.33) <0.001 0.25(0.11–0.56) <0.001
56–70 0.39(0.27–0.57) <0.001 0.33(0.18–0.62) <0.001
Recurrent myocardial infarction 640 0.37(0.12–1.09) 0.0720 1.72(0.29–10.25) 0.5487
41–55 0.53(0.29–0.97) 0.0414 1.65(0.53–5.13) 0.3831
56–70 0.60(0.34–1.08) 0.0913 0.79(0.25–2.46) 0.6915
Non-surgical major bleeding 640 0.46(0.15–1.40) 0.1746 3.68(0.75–18.09) 0.1079
41–55 0.16(0.06–0.42) <0.001 0.79(0.21–2.98) 0.7376
56–70 1.11(0.62–1.99) 0.7124 2.42(0.88–6.65) 0.0863
Stroke 640 0.47(0.13–1.67) 0.2435 1.27(0.22–7.35) 0.7837
41–55 0.48(0.22–1.07) 0.0733 0.72(0.23–2.22) 0.5683
56–70 0.70(0.34–1.44) 0.3397 0.65(0.24–1.71) 0.3846
Heart failure during hospitalization 640 0.24(0.15–0.40) <0.001 0.42(0.18–0.97) 0.0443
41–55 0.36(0.28–0.47) <0.001 0.45(0.29–0.72) <0.001
56–70 0.83(0.66–1.04) 0.1188 0.90(0.62–1.29) 0.5715
Cardiogenic shock 640 0.56(0.32–0.98) 0.0448 1.08(0.42–2.76) 0.8593
41–55 0.45(0.31–0.67) <0.001 0.53(0.28–1.03) 0.0629
56–70 0.69(0.49–0.98) 0.0387 0.94(0.55–1.60) 0.8205
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young people.
The rate of DM in our youngest patients (26%)
was similar to that of the entire cohorts in the
CREATE, ACTION, and GRACE registries (30%,
30%, and 23%). DM prevalence was 23.7% in a
Saudi national survey in 1995–2000 [14]. Similarly,
hypertension affected 28% of our youngest pa-
tients, compared with 26% national prevalence in
Saudi Arabia in the 1995–2000 survey [15].
What is disturbing is that 25% of those640 years
had history of IHD and for those aged >70 years
the proportion was 53%. That a quarter of the
youngest group of patients are presenting with
ACS with that past history suggests ongoing pro-
gression of disease either due to non compliance
with lifestyle changes or medical therapy or inad-
equate past revascularization. Increasing age was
also associated with greater probability for allforms of vascular disease and being on evidence
based treatment for vascular disease. Increasing
age was also more likely to be associated with
worse baseline renal function which is a predictor
of worse outcome in patients with ACS [16]. The
constellation of high prevalence of all these risk
factors therefore demands policymakers to target
primary and secondary prevention of IHD with a
high degree of urgency.Clinical presentation and treatment
Eighty-nine percent of STEMI patients <40 years
received reperfusion therapy. This was the high-
est rate achieved in any STEMI age group but
was lower than what was achieved by the middle
10% performing hospitals of the ACTION registry
at 94% [7]. Only 76% of STEMI patients >56 years
received any form of reperfusion therapy even
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onset. We did not study the factors that led to this
shortfall but this requires careful consideration in
order to reduce this therapeutic missed opportu-
nity. In addition increasing age was associated
with delayed presentation. Almost one-third of
patients >70 patients arrived more than 12 h from
symptom onset as can be seen in Graph 1. Even
when patients came in time TT was often given
late and the delay was more obvious with increas-
ing age. What was also disappointing that almost
half of patients >56 had prior history of IHD and
therefore should have been able to recognize
symptoms and seek help early. Patients were
either not sufficiently educated to seek early help
or had barriers that prevented them from seeking
early help. Financial considerations are not rele-
vant since medical care is entirely free to Saudi
nationals. Only 5% of patients utilized an ambu-
lance to come to hospital while the rest were usu-
ally transported by a relative. It is not also clear
whether any delay was related to the distance
needed to travel to hospitals or to congestion in
cities. Unfortunately even when these patients
presented late they were not offered primary
PCI to make up for not receiving TT. The overall
rate of primary PCI was very low but similar to
that reported by the CREATE registry [9]. This
was extremely low in comparison to the rates
achieved in ACTION (81%) or GRACE (58%) reg-
istries [7,6]. The underuse of primary PCI in spite
of the fact that we have more patients presenting
with STEMI and at younger age calls for major ef-
forts to change current practice by improving the
entire care process of managing such patients.Graph 1. The % and number of patients presenting initially to a hospita
acute ST segment elevation myocardial infarction in different age groupsThe public require better education in order to
shorten the time of symptom onset to presenta-
tion. Primary PCI service needs to be made more
available in all areas and made accessible for peo-
ple of all ages. The obstacles that lead to the very
low use of the ambulance service in all age groups
need to be explored since early diagnosis of STE-
MI before hospital arrival could influence direct
transfer of patients to PCI facilities thereby reduc-
ing delays and improving adoption of such evi-
denced based therapy. Initiatives such as that
proposed by the American Heart Association [17]
or the European Society of Cardiology Stent 4 Life
[18,19] or that proposed by others can be used or
modified to suit local needs [20]. It has been
shown that it is safe to return immediately almost
two-thirds of patients to their local hospital after
primary PCI [21].
The use of evidence based medical therapies
upon discharge was observed to be good in all
age groups. In particular the use of aspirin was
97% overall and was not significantly influenced
by age. This was lower than 99% achieved by the
top 10% performing hospitals in ACTION registry.
Overall use of statins upon discharge was 93% and
was not influenced by age. This compares with
94% achieved by the top 10% performing hospitals
in ACTION registry. The overall use of clopidogrel
was 84% and was not influenced by age. This com-
pares with 86% achieved by the top 10% perform-
ing hospitals in ACTION registry. The use of beta
blockers decreased with increasing age and was
highest in patients <40 at 85%. This was lower
than that achieved by the bottom 10% performing
hospitals in the ACTION registry (92%). The usel participating in the registry beyond 12 h from symptom onset with
in the SPACE registry (p < 0.001).
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AGE AND ITS RELATIONSHIP TO ACUTE CORONARY SYNDROMESof ACEI or ARB increased with age but did not ex-
ceed 78% in those >56 years. This was similar to
what was achieved by the bottom 10% performing
hospitals of the ACTION registry [7].
In-hospital outcome
The lowest in-hospital mortality was seen in pa-
tients aged 41–70 years while it was highest in pa-
tients >70 years. This undoubtedly reflected not
only the high prevalence of cardiovascular risk
factors and greater delays in presentation, but also
the sub-optimal care given to older patients. Older
STEMI patients were less likely to receive reperfu-
sion therapy or receive it very late. Even though
more patients P56 with all types of ACS were
being admitted with prior history of IHD the pro-
portion of past revascularization procedures with
PCI or CABG was not more than 24%. It is possible
that this may have also contributed to greater
morbidity and mortality amongst older patients
since these patients were receiving appropriate
evidence based therapies on admission. Recurrent
myocardial infarction, stroke, cardiogenic shock or
major non-surgical bleeding were not influenced
by age after multivariate adjustments for multiple
risk factors and variables. Finally the lowest risk
for heart failure development during hospitaliza-
tion was seen in the age group 41–55 years. This
perhaps reflects better myocardial function and
further explains the lowest observed mortality in
this age group. It is interesting to note that this
group had the highest rate of thrombolytic ther-
apy being administered within 12 h from the
symptom onset in STEMI patients, the highest
rate of GP IIb/IIIa inhibitor use, 70% rate of coro-
nary angiography, the highest rate of PCI and the
second highest rate of CABG. The observed high-
er rate of revascularization and the lower in-
hospital mortality require further study to see
whether this apparent early benefit is maintained
over the long term or not?Strengths and limitations
The hospitals that participated geographically
represented the whole country and included gen-
eral as well as tertiary care hospitals. Patient selec-
tion was avoided by requiring each hospital to
maintain a log of all possible ACS patients. The
use of the patient’s unique nationality or visitor
identity number did not allow double counting
of any patient even when being transferred be-
tween hospitals participating in the registry.
Twenty percent of the entire data were audited
independently by an outside auditor visiting sitesand found no major concerns in the originally
submitted data. Limitations include lack of long
term follow-up and in-depth enquiry of factors
that affected care or caused delayed presentation.
In particular, we did not obtain any information
from patients about their own expectation or satis-
faction with the care provided. Also we did not ob-
tain data from attending physicians regarding
why a course of treatment was followed or not.Conclusions
Young ACS patients were more likely to be
smokers and to present with STEMI. Older pa-
tients were more likely to have DM, HTN, present
with NSTEMI or UA, have delayed presentation,
have multi-vessel CAD and were apparently trea-
ted less aggressively. They suffer from higher
in-hospital mortality. There is an urgent need for
a national prevention program as well as a sys-
tematic improvement in the care for patients with
ACS including a system of care for STEMI
patients. For older patients there is a need to iden-
tify medical as well as social factors that influence
the therapeutic management plans.Conflict of interest
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